Related Experiment Video

Updated: Aug 25, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

The rostral mesencephalon in Parkinson's disease and Alzheimer's disease

S Hunter

    Acta Neuropathologica
    |January 1, 1985
    PubMed

    Insights

    Parkinson's and Alzheimer's diseases impact the brainstem. Parkinson's disease shows significant neuronal loss and Lewy bodies in the Edinger Westphal nucleus, unlike Alzheimer's disease.

    Area of Science:

    • Neuroscience
    • Neuropathology

    Background:

    • The study investigates neuropathological changes in the rostral mesencephalon, specifically the Edinger Westphal nucleus, in neurodegenerative diseases.
    • Understanding these changes is crucial for elucidating disease mechanisms and potential therapeutic targets.

    Observation:

    • Light microscopy was used to examine brain tissue from patients with idiopathic Parkinson's disease (PD), Alzheimer's disease (AD), and senile dementia of the Alzheimer's type (SDAT).
    • Specific focus was placed on the rostral mesencephalon at the posterior commissure level, including the Edinger Westphal nucleus, central gray matter, and pretectal region.

    Findings:

    • In Parkinson's disease, the Edinger Westphal nucleus exhibited Lewy bodies (3% of neurons), neurofibrillary degeneration (2%), and substantial neuronal loss (54%).
    • Alzheimer's disease cases showed neurofibrillary degeneration in 2% of Edinger Westphal neurons, with no apparent neuronal loss. SDAT cases had rare neurofibrillary degeneration.
    • Pathological changes in the Edinger Westphal nucleus in PD and AD resemble those in basal forebrain cholinergic centers. Lewy bodies were confined to the nucleus of Darkschewitsch in PD, while neurofibrillary tangles were found in this nucleus in both disease groups.

    Implications:

    • The observed pathology in the Edinger Westphal nucleus suggests a broader impact of neurodegenerative diseases beyond traditionally studied brain regions.
    • Findings indicate distinct neuropathological profiles in the mesencephalon between Parkinson's disease and Alzheimer's disease.
    • This research contributes to understanding the differential involvement of brainstem nuclei in neurodegenerative disorders.

    More Related Videos

    Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model06:07

    Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

    Published on: June 23, 2023

    Technique for Intranasal Administration of α-Synuclein Aggregates04:49

    Technique for Intranasal Administration of α-Synuclein Aggregates

    Published on: November 8, 2024

    Related Concept Videos

    Neural Regulation01:37

    Neural Regulation

    Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
    Alzheimer Disease ll: Pathophysiology01:23

    Alzheimer Disease ll: Pathophysiology

    Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
    Parkinson Disease l: Introduction01:24

    Parkinson Disease l: Introduction

    Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
    Parkinson Disease ll: Pathophysiology01:24

    Parkinson Disease ll: Pathophysiology

    Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...